Author:
Nakaya Aya,Fujita Shinya,Satake Atsushi,Nakanishi Takahisa,Azuma Yoshiko,Tsubokura Yukie,Konishi Akiko,Hotta Masaaki,Yoshimura Hideaki,Ishii Kazuyoshi,Ito Tomoki,Nomura Shosaku
Abstract
The survival of multiple myeloma patients has improved significantly over the last several decades. However, the median overall survival of these patients remains less than 5 years. In this report, we discuss 4 cases of multiple myeloma patients that showed long survival. Interestingly, these patients had severe organ damage at diagnosis, used only conventional agents, and did not always show deep response. Although current guidelines recommend novel agents to achieve deep response, the current cases suggest that some multiple myeloma patients may not need intensive treatment. Here, we discuss 4 cases of symptomatic but indolent transplant-ineligible myeloma.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献